An Impactful Patient Experience That Has Altered My Approach to Mantle Cell Lymphoma

Suchitra Sundaram, MD

January 18, 2023

Suchitra Sundaram, MD, describes an impactful experience early in her career where she helped a newly diagnosed patient with mantle cell lymphoma (MCL) choose an appropriate frontline therapy.

The range of established regimens for MCL does more than provide options for first-line treatment, Dr Sundaram suggests — it also allows flexibility in the planning of extended treatment so that patients can best shape a therapeutic course to match their own circumstances and desired quality of life.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: An Impactful Patient Experience That Has Altered My Approach to Mantle Cell Lymphoma - Medscape - Jan 18, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.